UNSPSC 51392608: Phenylpropanolamine bitartrate

This classification denotes an adrenergic agonist with the molecular formula C9H13NO.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B48FTC099P, chemically known as (r*,s*)-(+-)-alpha-(1-aminoethyl)benzenemethanol bitartrate but more generally known as phenylpropanolamine bitartrate, which bears US NIH Compound Identifier 62941. European Medicines Agency schedules Phenylpropanolamine bitartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03781MIG.

UNSPSC 51392608 Phenylpropanolamine bitartrate is a Commodity code whose recent state and local opportunities show no activity aligned with the code's nominal pharmaceutical ingredient scope. The single relevant posting — Seminole County, Florida's IFB60459723LAS issued June 30, 2026 — solicits Naloxone and Safe Drug Deactivation Systems, not phenylpropanolamine bitartrate. A second recent opportunity posted by the Texas Health and Human Services Commission (HHS0017013, April 3, 2026) is an RFI for direct-to-manufacturer prescription programs that does not target this specific pharmaceutical input. The code shows minimal recent state and local procurement activity aligned to its actual product scope.

Seminole County's Naloxone procurement represents the only substantive recent state-local opportunity posted under this code family. The county seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the response deadline was July 26, 2023 at 2:00 pm. The contract carries a two-year initial term with one-year renewal option, requires E-Verify compliance and drug-free workplace certification, and includes FEMA compliance requirements. The Texas HHS RFI, while posted recently (April 3, 2026), focuses on direct manufacturer contracting models for broader pharmacy benefit management rather than procurement of phenylpropanolamine bitartrate itself. Business development professionals should verify whether phenylpropanolamine bitartrate appears in downstream RFPs from either issuing body before allocating pursuit resources to this code.